These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

920 related articles for article (PubMed ID: 9700655)

  • 1. Mechanisms of neurofibrillary degeneration and the formation of neurofibrillary tangles.
    Iqbal K; Alonso AC; Gong CX; Khatoon S; Pei JJ; Wang JZ; Grundke-Iqbal I
    J Neural Transm Suppl; 1998; 53():169-80. PubMed ID: 9700655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of neurofibrillary degeneration and pharmacologic therapeutic approach.
    Iqbal K; Alonso AD; Gondal JA; Gong CX; Haque N; Khatoon S; Sengupta A; Wang JZ; Grundke-Iqbal I
    J Neural Transm Suppl; 2000; 59():213-22. PubMed ID: 10961432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration.
    Wang JZ; Grundke-Iqbal I; Iqbal K
    Eur J Neurosci; 2007 Jan; 25(1):59-68. PubMed ID: 17241267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention.
    Iqbal K; Grundke-Iqbal I
    J Cell Mol Med; 2008; 12(1):38-55. PubMed ID: 18194444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological targets to inhibit Alzheimer neurofibrillary degeneration.
    Iqbal K; Alonso Adel C; El-Akkad E; Gong CX; Haque N; Khatoon S; Tsujio I; Grundke-Iqbal I
    J Neural Transm Suppl; 2002; (62):309-19. PubMed ID: 12456074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance and mechanism of Alzheimer neurofibrillary degeneration and therapeutic targets to inhibit this lesion.
    Iqbal K; Alonso Adel C; El-Akkad E; Gong CX; Haque N; Khatoon S; Pei JJ; Tsujio I; Wang JZ; Grundke-Iqbal I
    J Mol Neurosci; 2002; 19(1-2):95-9. PubMed ID: 12212801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer neurofibrillary degeneration: therapeutic targets and high-throughput assays.
    Iqbal K; Alonso Adel C; El-Akkad E; Gong CX; Haque N; Khatoon S; Pei JJ; Tanimukai H; Tsujio I; Wang JZ; Grundke-Iqba I
    J Mol Neurosci; 2003; 20(3):425-9. PubMed ID: 14501027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ubiquitination and abnormal phosphorylation of paired helical filaments in Alzheimer's disease.
    Iqbal K; Grundke-Iqbal I
    Mol Neurobiol; 1991; 5(2-4):399-410. PubMed ID: 1726645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of neurofibrillary degeneration in Alzheimer's disease.
    Iqbal K; Alonso AC; Gong CX; Khatoon S; Singh TJ; Grundke-Iqbal I
    Mol Neurobiol; 1994; 9(1-3):119-23. PubMed ID: 7888088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycosylation of microtubule-associated protein tau: an abnormal posttranslational modification in Alzheimer's disease.
    Wang JZ; Grundke-Iqbal I; Iqbal K
    Nat Med; 1996 Aug; 2(8):871-5. PubMed ID: 8705855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tau pathology in Alzheimer disease and other tauopathies.
    Iqbal K; Alonso Adel C; Chen S; Chohan MO; El-Akkad E; Gong CX; Khatoon S; Li B; Liu F; Rahman A; Tanimukai H; Grundke-Iqbal I
    Biochim Biophys Acta; 2005 Jan; 1739(2-3):198-210. PubMed ID: 15615638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of tau-induced neurodegeneration.
    Iqbal K; Liu F; Gong CX; Alonso Adel C; Grundke-Iqbal I
    Acta Neuropathol; 2009 Jul; 118(1):53-69. PubMed ID: 19184068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological approaches of neurofibrillary degeneration.
    Iqbal K; Grundke-Iqbal I
    Curr Alzheimer Res; 2005 Jul; 2(3):335-41. PubMed ID: 15974899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular pathology of Alzheimer neurofibrillary degeneration.
    Iqbal K; Alonso A; Gong C; Khatoon S; Kudo T; Singh T; Grundke-Iqbal I
    Acta Neurobiol Exp (Wars); 1993; 53(1):325-35. PubMed ID: 8317268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanism of Alzheimer's neurofibrillary degeneration and therapeutic intervention.
    Iqbal K; Grundke-Iqbal I
    Ann N Y Acad Sci; 1996 Jan; 777():132-8. PubMed ID: 8624075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal hyperphosphorylation of tau: sites, regulation, and molecular mechanism of neurofibrillary degeneration.
    Wang JZ; Xia YY; Grundke-Iqbal I; Iqbal K
    J Alzheimers Dis; 2013; 33 Suppl 1():S123-39. PubMed ID: 22710920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of neurofibrillary degeneration: a promising approach to Alzheimer's disease and other tauopathies.
    Iqbal K; Grundke-Iqbal I
    Curr Drug Targets; 2004 Aug; 5(6):495-502. PubMed ID: 15270196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dephosphorylation of Alzheimer paired helical filaments by protein phosphatase-2A and -2B.
    Wang JZ; Gong CX; Zaidi T; Grundke-Iqbal I; Iqbal K
    J Biol Chem; 1995 Mar; 270(9):4854-60. PubMed ID: 7876258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer paired helical filaments. Restoration of the biological activity by dephosphorylation.
    Iqbal K; Zaidi T; Bancher C; Grundke-Iqbal I
    FEBS Lett; 1994 Jul; 349(1):104-8. PubMed ID: 8045285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurofibrillary degeneration and microtubule associated protein tau.
    Yen SH; Liu WK
    Chin J Physiol; 1992; 35(4):357-66. PubMed ID: 1308732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.